BioClin has been acquired by Trimb Healthcare
Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.
Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.
Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.
Oaklins' team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.
Talk to the deal team
Casper Oude Essink
Senior Associate
Amsterdam, NetherlandsOaklins Netherlands
Related deals
Jonelinvest and 3d investors have acquired a minority stake in Studio 100
Jonelinvest NV and 3d investors have acquired a minority stake in Studio 100.
Learn moreKalsbeek has been acquired by Normec Group
The shareholders of Kalsbeek BV have sold the company to Normec Group.
Learn moreThe Archer Group has been acquired by Bounteous, a portfolio company of Mountaingate Capital
The Archer Group, a leader in digital strategy, experience design, usability research, technology and media, has been acquired by Bounteous, a digital experience agency.
Learn more